Physician profile
David A Stoller
NPI 1952364531
$3,334.01
in general payments reported to CMS, 2019-2025
18 companies · $26.67 in 2025
The $26.67 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,419 · 2020: $150 · 2021: $362 · 2022: $521 · 2023: $517 · 2024: $339 · 2025: $26.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $972.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $761.59 | 2021-2025 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $323.97 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $323.35 | 2019 | |
| Amgen INC. | $248.20 | 2024 | Krystexxa |
| Nabriva Therapeutics, Plc | $124.14 | 2020-2022 | |
| Horizon Therapeutics Plc | $116.66 | 2023 | Krystexxa |
| Grt US Holding, INC. | $93.76 | 2022 | |
| Sandoz INC. | $78.69 | 2019-2021 | |
| Alfasigma USA, INC. | $56.04 | 2020 | |
| Smith+Nephew, INC. | $41.45 | 2023 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $40.72 | 2019 | |
| Zyla Life Sciences, INC. | $35.15 | 2019 | |
| Organogenesis INC. | $33.71 | 2020-2021 | |
| Assertio Therapeutics, INC. | $27.93 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $25.70 | 2024 | |
| Abbvie INC. | $17.29 | 2021 | |
| Almirall LLC | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stoller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.